The benefits of the Pan African Clinical Trials Registry (PACTR) will be felt by a wide audience including policy makers, health professionals,
clinical trial funders, development agencies, researchers, and the lay public.
Policy makers will benefit from the regulatory aspects of the Registry as they will be able to keep track of all clinical
trial activity in their country and/or region. They will have a clearer idea of how clinical trial activity is serving the health
needs of the population, as the Registry will provide them with up-to-date information on the nature and location of clinical
trials being conducted. Policy makers will also benefit from the information provided by those comprehensive systematic reviews
that will incorporate trial information from the Registry.
Health professionals will be able to find out information on trials in progress so that they can advise patients about
appropriate trials in which to participate. Health professionals will also benefit from the evidence provided by comprehensive
systematic reviews which may include information directly from the PACTR.
Clinical trial funders may obtain information on what research is being conducted, where the research is being conducted
and by whom. This information will enable them to allocate their funding in a more appropriate and effective manner.
Numerous development agencies have dedicated funding for the development and enhancement of clinical trial activity and
capabilities in Africa. The information contained in the database will provide them with a better view and understanding of the
clinical trial activity and capacity in Africa.
Through a search of the PACTR database, researchers will be able to identify "gaps" in the research so that they
can better focus their research objectives and activities.
The PACTR will also assist in meeting the ethical obligations of clinical trials to their participants. The lay public
will be able to find out about clinical trials being conducted in their neighbourhoods. From the information provided they will be
able to decide if they are interested and or eligible to participate in a particular trial.
 Although Cochrane systematic reviews are not a core objective of the PACTR project, inclusion of recent trial information
in the Registry will facilitate the accessibility of this information for the conduct of up-to-date systematic reviews.